(“NetScientific” or the “Company” or the “Group”)
Results of Annual General Meeting
London, UK – 15th June 2016 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic biomedical and healthcare technology group, announces that all resolutions proposed at today’s Annual General Meeting, were duly passed.
NetScientific has over the past year undergone a transformation, with a rationalisation of its portfolio and restructuring of the management team, resulting in a streamlined group focused on holding majority positions and delivery and maximising shareholder value from its investments in digital health, diagnostics and therapeutics.
– Ends –
For more information, please contact:
|
NetScientific François R. Martelet, M.D., CEO Ian Postlethwaite, CFO
|
Tel: +44 (0)20 3514 1800 |
|
Investec (NOMAD and broker) Gary Clarence / Daniel Adams |
Tel: +44 (0)20 7597 4000 |
|
Consilium Strategic Communications Mary-Jane Elliott / Chris Gardner / Jessica Hodgson / Chris Welsh / Laura Thornton |
Tel: +44 (0)20 3709 5700 netscientific@consilium-comms.com |
About NetScientific Plc
NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people’s lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net.
END
RAGFAMJTMBBBBBF
